These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 21305698

  • 1. A strategy for neuraminidase inhibitors using mechanism-based labeling information.
    Hinou H, Miyoshi R, Takasu Y, Kai H, Kurogochi M, Arioka S, Gao XD, Miura N, Fujitani N, Omoto S, Yoshinaga T, Fujiwara T, Noshi T, Togame H, Takemoto H, Nishimura S.
    Chem Asian J; 2011 Apr 04; 6(4):1048-56. PubMed ID: 21305698
    [Abstract] [Full Text] [Related]

  • 2. Aglycone-focused randomization of 2-difluoromethylphenyl-type sialoside suicide substrates for neuraminidases.
    Kai H, Hinou H, Nishimura S.
    Bioorg Med Chem; 2012 Apr 15; 20(8):2739-46. PubMed ID: 22410247
    [Abstract] [Full Text] [Related]

  • 3. Macrocyclic mechanism-based inhibitor for neuraminidases.
    Kai H, Hinou H, Naruchi K, Matsushita T, Nishimura S.
    Chemistry; 2013 Jan 21; 19(4):1364-72. PubMed ID: 23233350
    [Abstract] [Full Text] [Related]

  • 4. Characterization of Vibrio cholerae neuraminidase by a novel mechanism-based fluorescent labeling reagent.
    Hinou H, Kurogochi M, Shimizu H, Nishimura S.
    Biochemistry; 2005 Sep 06; 44(35):11669-75. PubMed ID: 16128567
    [Abstract] [Full Text] [Related]

  • 5. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.
    Levin Perlman S, Jordan M, Brossmer R, Greengard O, Moscona A.
    Virology; 1999 Dec 05; 265(1):57-65. PubMed ID: 10603317
    [Abstract] [Full Text] [Related]

  • 6. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
    Bossart-Whitaker P, Carson M, Babu YS, Smith CD, Laver WG, Air GM.
    J Mol Biol; 1993 Aug 20; 232(4):1069-83. PubMed ID: 8371267
    [Abstract] [Full Text] [Related]

  • 7. Multivalency and the mode of action of bacterial sialidases.
    Thobhani S, Ember B, Siriwardena A, Boons GJ.
    J Am Chem Soc; 2003 Jun 18; 125(24):7154-5. PubMed ID: 12797770
    [Abstract] [Full Text] [Related]

  • 8. One-bead-one-inhibitor-one-substrate screening of neuraminidase activity.
    Ying L, Gervay-Hague J.
    Chembiochem; 2005 Oct 18; 6(10):1857-65. PubMed ID: 16149103
    [Abstract] [Full Text] [Related]

  • 9. Inhibition studies on Vibrio cholerae neuraminidase.
    Brossmer R, Keilich G, Ziegler D.
    Hoppe Seylers Z Physiol Chem; 1977 Mar 18; 358(3):391-6. PubMed ID: 856712
    [Abstract] [Full Text] [Related]

  • 10. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase.
    Haselhorst T, Wilson JC, Thomson RJ, McAtamney S, Menting JG, Coppel RL, von Itzstein M.
    Proteins; 2004 Aug 01; 56(2):346-53. PubMed ID: 15211517
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
    Arioka S, Sakagami M, Uematsu R, Yamaguchi H, Togame H, Takemoto H, Hinou H, Nishimura S.
    Bioorg Med Chem; 2010 Feb 15; 18(4):1633-40. PubMed ID: 20097567
    [Abstract] [Full Text] [Related]

  • 13. Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata.
    Ryu YB, Curtis-Long MJ, Lee JW, Kim JH, Kim JY, Kang KY, Lee WS, Park KH.
    Bioorg Med Chem; 2009 Apr 01; 17(7):2744-50. PubMed ID: 19285413
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prenylated pterocarpans as bacterial neuraminidase inhibitors.
    Nguyen PH, Nguyen TN, Kang KW, Ndinteh DT, Mbafor JT, Kim YR, Oh WK.
    Bioorg Med Chem; 2010 May 01; 18(9):3335-44. PubMed ID: 20363636
    [Abstract] [Full Text] [Related]

  • 18. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
    Watson KG, Cameron R, Fenton RJ, Gower D, Hamilton S, Jin B, Krippner GY, Luttick A, McConnell D, MacDonald SJ, Mason AM, Nguyen V, Tucker SP, Wu WY.
    Bioorg Med Chem Lett; 2004 Mar 22; 14(6):1589-92. PubMed ID: 15006410
    [Abstract] [Full Text] [Related]

  • 19. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
    Finley JB, Atigadda VR, Duarte F, Zhao JJ, Brouillette WJ, Air GM, Luo M.
    J Mol Biol; 1999 Nov 12; 293(5):1107-19. PubMed ID: 10547289
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.